Bayer reports positive early data for Parkinson’s cell therapy

The therapy, developed by Bayer’s Bluerock Therapeutics subsidiary, appeared safe and well-tolerated in a 12-person clinical trial.

Published Aug. 28, 2023

Bayer reports positive early data for Parkinson’s cell therapy | BioPharma Dive: Bayer reports positive early data for Parkinson’s cell therapy
Joe
Author: Joe

Facebook
Twitter
LinkedIn

Search

Posts

Donate

Share information about Parkinson's disease and the need for donations with your friends and family.
Together, we can make a difference in the lives of those affected by this condition.
Donate Today

Navigation

Information

Socials

Facebook-f Twitter Linkedin-in Instagram

Subscribe to Our Mailing List

  • Early Onset Parkinson’s Disease CLG, 77 Lower Camden Street, Dublin DO2 XE80
  • Company Number 684095
  • Registered Charity Number 20206267
  • Revenue Number CHY22875

© 2023 EOPD - Early Onset Parkinson's Diesease

Back to Top

Site Design | McKenna Creative